Resources

For the latest in nextgen biomed, sign up for our monthly newsletter to be among the first to receive exclusive insights, in-depth market analyses, and expert articles directly to your inbox

Antibody & Protein Engineering

FDA Approves Takeda’s Subcutaneous Ulcerative Colitis mAb

The company can now sell their biologic for ulcerative colitis in a subcutaneous form on the US market.

Navigating the Pharma R&D Regulatory Landscape 2023

Our ‘Navigating the Regulatory Landscape' eBook has been designed to provide you with invaluable insights into the intricacies of regulations & policies surrounding the challenges and opportunities of Real-World Data, genome editing, biomedical informatics, manufacturing and many more.

How Adaptimmune's T-Cell Therapy Development Pipeline Became a Commercialisation Success Story

Adaptimmune has developed from a strategic collaboration with GSK and embarked on a highly successful journey towards developing cancer immunotherapy treatments.
Antibody & Protein Engineering

Navigating the Pharma R&D Regulatory Landscape 2023

Our ‘Navigating the Regulatory Landscape’ eBook has been designed to provide you with invaluable insights into the intricacies of regulations & policies surrounding the challenges and opportunities of Real-World Data, genome editing, biomedical informatics, manufacturing and many more.
Drug Discovery & Development

European Commission Approves Genmab’s Subcutaneous Bispecific Antibody Tepkinly

The approval follows positive results from Genmab's 'Epcore' phase I/II clinical trial.
Oligo Chemistry

How Do Regulatory Considerations Impact the Clinical Development of Oligonucleotide Therapies?

What are the regulatory considerations that need to be made in the clinic for oligonucleotide therapies? What's the existing guidance for this emerging modality?
Peptide Chemistry

Trends and Challenges in Peptide Bioanalysis and Production

Here, we investigate some of the main trends and challenges in peptide bioanalysis such as non-specific binding, and look at how they can be circumvented.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery